Elevance Health (ELV) Bolsters CarelonRx With Paragon Buyout
The infusion services from Paragon Healthcare are expected to complement Elevance Health's (ELV) suite of pharmacy services.
Elevance Heath: Financial Growth And Technical Strength Indicate A Buy
Elevance Health showcased strong financial growth in Q4 and the full year of 2023, highlighting increased revenues and earnings per share. Technical analysis indicates a bullish trend, with the sto...
ELV or GDRX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attracti...
Why Is Elevance Health (ELV) Up 6.6% Since Last Earnings Report?
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Here's Why Elevance Health (ELV) Gained But Lagged the Market Today
Elevance Health (ELV) closed at $512.17 in the latest trading session, marking a +0.55% move from the prior day.
Elevance Health Q4: Undervalued Despite Risks To Core Business
Elevance Health reported Q4 earnings that beat expectations for both EPS and revenue. The company exceeded its 2023 guidance but disappointed with its 2024 guidance, predicting flat to low single-d...
Elevance Health: Time To Buy This Incredible Dividend Growth Stock
Elevance Health rewarded shareholders with a 10.1% hike in its quarterly dividend per share. The managed care company's operating revenue and adjusted diluted EPS climbed in the fourth quarter. Ele...
Elevance (ELV) Q4 Earnings Beat on Premium Growth, Dividend Hiked
Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.
Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates
Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago.
Elevance Health beats quarterly sales estimates
Elevance Health reported fourth-quarter sales that beat analysts' estimates on Wednesday, helped by higher premiums from its health insurance business and demand at its Carelon health services busi...
Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics
Get a deeper insight into the potential performance of Elevance Health (ELV) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estim...
Can Higher Costs Affect Elevance Health's (ELV) Q4 Earnings?
Elevance Health's (ELV) fourth-quarter results are likely to reflect higher premiums and product revenues.
ELV or HQY: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY). But which of these two companies is the best option for those lookin...
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Here is how Elevance Health (ELV) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.
Why You Should Retain Elevance (ELV) Stock in Your Portfolio
Elevance's (ELV) Carelon unit is expected to benefit from improving performance in the Behavioral Health business and post-acute care services.
Related Companies